Corbus Pharmaceuticals
CRBP
CRBP
72 hedge funds and large institutions have $19.7M invested in Corbus Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 24 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
28% less capital invested
Capital invested by funds: $27.3M → $19.7M (-$7.56M)
38% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 24
56% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 18
Holders
72
Holding in Top 10
1
Calls
$240K
Puts
$151K
Top Buyers
| 1 | +$484K | |
| 2 | +$275K | |
| 3 | +$204K | |
| 4 |
D.E. Shaw & Co
New York
|
+$86.8K |
| 5 |
IEFM
IQ EQ Fund Management
Dublin 2,
Ireland
|
+$61.9K |
Top Sellers
| 1 | -$1.44M | |
| 2 | -$1.04M | |
| 3 | -$591K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$519K |
| 5 |
PCM
Penserra Capital Management
Orinda,
California
|
-$330K |